Bruker Corp (BRKR) officer Mark Munch, Executive Vice President and President of Bruker Nano Inc., exercised options for 2,000 shares of common stock on September 15, 2026 at an exercise price of $22.19 per share and sold the 2,000 acquired shares at $52.87 per share the same day. The stock option, originally granted on October 4, 2016, fully covered these 2,000 shares and was reported as having no remaining balance after the exercise. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Bruker Corporation (BRKR) reports that officer Mark R. Munch has filed a notice under Rule 144 to sell 2,000 shares of Bruker common stock through Morgan Stanley Smith Barney on NASDAQ. The planned sale has an indicated aggregate market value of $105,740 based on the filing data.
The notice states that Bruker had 152,359,316 shares of common stock outstanding as of September 15, 2026. The filing also lists prior sales by Munch of 2,000 shares on July 15, 2026 and 2,000 shares on August 14, 2026, with reported aggregate values of $120,500 and $115,200, respectively.
BRUKER CORP (BRKR) reported equity compensation awards to officer Burkhard Prause. He received a grant of 3,303 shares of Common Stock in the form of Restricted Stock Units, which vest in equal installments on the first, second, third, and fourth anniversaries of the August 15, 2026 grant date. He was also granted Stock Options for 2,678 shares of Common Stock at an exercise price of $57.70 per share, vesting on the same four annual schedule and expiring on August 15, 2036. Following the Common Stock grant, his directly held Common Stock position is 28,461 shares.
Bruker Corp (BRKR) reported insider equity transactions by Wolfgang Pusch, President BMID Group. On August 17, 2026, he sold 3,473 shares of Common Stock at $56.90 per share. On August 15, 2026, he received equity awards: 3,120 Restricted Stock Units that vest in four equal annual installments, and 2,529 stock options with a $57.70 exercise price, also vesting in four equal annual installments and expiring on August 15, 2036.
BRUKER CORP (symbol: BRKR) is the issuer of record for a Form 4 filing submitted to the SEC.
BRUKER CORP (BRKR) reported that officer Juergen Srega, President CALID, received equity awards. He was granted 16,898 shares of common stock in the form of Restricted Stock Units, which vest in four equal annual installments starting on the first anniversary of the August 15, 2026 grant date, increasing his directly held common shares to 174,625. He was also granted a stock option for 13,698 shares of common stock at an exercise price of $57.70 per share, vesting in four equal annual installments from the same grant date, exercisable from August 15, 2027 until August 15, 2036.
BRUKER CORP (BRKR) reported equity awards and related tax withholding for President & CEO Frank H. Laukien. On August 15, 2026, he received a grant of 71,651 stock options with an exercise price of $63.47 per share, vesting in four equal annual installments starting on the first anniversary of the grant date. He also received 29,463 Restricted Stock Units, which vest in four equal annual installments on the same schedule. On that date, 4,760 common shares were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted RSUs. Indirect holdings include 336,607 common shares held by a daughter.
BRUKER CORP (BRKR) reported equity compensation transactions for Executive Vice President and CFO Gerald N. Herman on August 15, 2026. He received 15,794 shares of Common Stock as Restricted Stock Units that vest in four equal annual installments starting one year after the grant date, and a stock option for 12,803 shares of Common Stock at an exercise price of $63.47 per share, also vesting in four equal annual installments. The option expires on August 15, 2036. On the same date, 2,724 shares of Common Stock were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted restricted stock units.
BRUKER CORP (BRKR) reported multiple equity compensation and trading transactions by executive vice president Mark Munch. On August 15, 2026, he received a grant of 11,708 stock options with an exercise price of $57.70 per share, vesting in four equal annual installments, and a grant of 14,443 Restricted Stock Units that also vest in four equal annual installments. That same day, 2,984 shares of common stock were withheld by the company to satisfy tax obligations upon vesting of previously granted RSUs. On August 14, 2026, he exercised 2,000 stock options at $22.19 per share, received 2,000 shares of common stock, and sold 2,000 shares at $57.60 per share pursuant to a Rule 10b5-1 trading plan.
Bruker Corporation has a holder planning to sell 3,473 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $197,613.70, to be sold on or after August 17, 2026 on NASDAQ.
The same holder reports prior sales of restricted common stock back to the issuer in the past three months, including 847 shares on August 9, 2026, 565 shares on August 10, 2026, 605 shares on August 11, 2026, and 1,456 shares on August 15, 2026.